Outset Medical, Inc. - OM Forward P/S Multiple
Outset Medical, Inc. (OM) maintains a steady cash flow driven by high-demand cartridges for Tablo. This chart on GURU.Markets illustrates the trend of the forward P/S ratio, where 0.60 represents the current value of the metric. Business efficiency is based on system assembly in the US and Mexico, as well as the utilization of contract manufacturers for component production and cloud-based patient support.
Outset Medical Corp (OM) - metric breakdowns and financial figures
- current price and projected stock value:
- issuer market value details:
- issuer book value statistics:
- company liabilities and liquidity data:
Debt to Equity Outset Medical, Inc.|OM - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Outset Medical, Inc.|OM - Aggregate Debt Obligations|Debts to Book Capitalization Outset Medical Corp|OM - Long-Term Debt|Company Short-Term Debt Outset Medical|Quick Liquidity Indicator outsetmedical.com
- financial results and valuation multiples details:
OM - Net Profit|Projected Future Earnings Outset Medical, Inc.|OM - Business Payback Period|Future Price to Earnings Outset|OM - Market Cap to Earnings and Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Outset Medical Corp|OM - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Outset Medical|OM - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months outsetmedical.com|OM - Earnings per share growth this year|Expected earnings per share growth for next year Outset Medical, Inc.
- sales and revenue data:
Summary company analysis:Outset Medical OM
Sales diversification between hospitals and private patients in the US provides Outset Medical, Inc. (OM) with resilience against medical center budget fluctuations. The business's forward P/S ratio compares the company's current valuation with expected revenue, allowing investors to determine the asset's degree of overheating and find a balance between growth potential and the risk of a deep correction when analyzing this chart.
Competitor analysis
Forward P/S Multiple DXCM (Dexcom)|PEN: Market Cap to Projected Revenue|Novanta Corp - Forward P/S Multiple|Market Cap to Expected Sales Ratio Haemonetics Company HAE|INSP: Forward P/S Multiple|Forward Price-to-Revenue Multiple procept-biorobotics.com|CNMD (CONMED) - Forward P/S Multiple|Forward P/S Multiple Pulse Biosciences Inc|Price-to-Projected Revenue Ratio InMode Corp (INMD)|Price-to-Projected Revenue Ratio PMI (Picard Group)|Surmodics, Inc. - Forward Price-to-Revenue Multiple|Forward Price to Sales SENS|NeuroPace - Forward P/S Multiple|Market Cap to Future Revenue Ratio Tactile Systems Technology|SANUWAVE Health, Inc. (SNWV) - Price-to-Projected Revenue Ratio|Projected Price to Revenue Electromed ELMD|Forward Price-to-Revenue Multiple LNSR|Forward P/S Multiple avitamedical.com|Forward P/S Multiple PROF|Market Cap to Expected Sales Ratio bairdmed.com|Price-to-Projected Revenue Ratio EDAP TMS EDAP|APYX (Apyx Medical Corp) - Future Price to Revenue|ICCM - Price-to-Projected Revenue Ratio|Pulmonx Corporation (LUNG) - Forward Price-to-Revenue Multiple|TELA: Forward P/S Multiple|Market Cap to Future Revenue Ratio CytoSorbents Corporation (CTSO)|Price-to-Projected Revenue Ratio Sensus Healthcare Corp|Market Cap to Projected Revenue ZYXI (Zynex Corp)|Forward Price-to-Revenue Multiple ECOR (electroCore, Inc.)|Price to Expected Revenue Ratio RBOT|Price-to-Projected Revenue Ratio Inspira Technologies IINN|SeaStar Medical Holding Corporation (ICU) - Market Cap to Future Revenue Ratio|IRIX: Forward Price-to-Revenue Multiple|INBS - Forward P/S Multiple|XAIR (beyondair.net) - Forward Price-to-Revenue Multiple|PFSA: Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio STRATA Skin Sciences Inc.|glucotrack.com (GCTK) - Market Cap to Expected Sales Ratio|Forward P/S Multiple NAOV|VERO - Market Cap to Future Revenue Ratio|Nuwellis, Inc. - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio AEMD (aethlonmedical.com)|ASXC: Forward Price-to-Revenue Multiple|Forward Price to Sales AVGR (Avinger Inc.)|BioSig Technologies, Inc (BSGM) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Cutera Inc|KNW (Know Labs, Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio inarimedical.com NARI|Forward P/S Multiple NVRO|reshapelifesciences.com - Market Cap to Projected Revenue|Forward P/S Multiple SILK (Silk Road Medical Inc.)
